In this Viewpoint, 2016 Lasker Award winners Ralf Bartenschlager, Charles Rice, and Michael Sofia discuss their work developing a system to study the replication of hepatitis C virus and a class of antivirals to treat the infection.
This Clinical Evidence Synopsis summarizes a Cochrane review of clinical trials comparing the effects of antiviral therapies plus oral corticosteroids vs oral corticosteroids alone for patients presenting within 72 hours of onset of Bell palsy.
This Viewpoint calls for government support for providing direct–acting antiviral treatment to American Indian/Alaska Native population, which is disproportionately infected by hepatitis C virus.
This statement from the International Antiviral Society–USA updates recommendations for the use of antiretroviral drugs (ARVs) to treat adults with established HIV infection and to prevent HIV infection among persons at risk of infection.
This Viewpoint urges greater involvement of primary care physicians in screening patients for risky sexual behaviors and prescribing preexposure prophylactic antiviral medication to those at risk of HIV infection.
This article reviews the antiviral drugs available to treat influenza this season—including oseltamivir and zanamivir—as well as their indications and possible adverse effects.
This randomized trial reports a lower incidence of hepatitis B virus (HBV) infection and reactivation in patients seropositive for the hepatitis B surface antigen with untreated diffuse large B-cell lymphoma receiving treatment with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone.
Günthard and coauthors report the 2014 recommendations of the International Antiviral Society–USA Panel on antiretroviral treatment of adult human immunodeficiency virus (HIV) infection.
You currently have no searches saved.